Ersan Oflar
Overview
Explore the profile of Ersan Oflar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
73
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koyuncu A, Yildiz C, Ocal L, Kalkan S, Kilicgedik A, Gursoy M, et al.
PLoS One
. 2024 Nov;
19(11):e0314401.
PMID: 39565758
[This corrects the article DOI: 10.1371/journal.pone.0282054.].
2.
Kocabas U, Ergin I, Yavuz V, Altin C, Kaplan M, Oztekin G, et al.
ESC Heart Fail
. 2024 Sep;
12(1):434-446.
PMID: 39340234
Aims: We aimed to determine the use of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and to identify clinical factors associated with their use in patients with heart failure (HF) in a...
3.
Oflar E, Karabulut D, Yildiz C, Sinoplu H, Donmez E, Koyuncu A, et al.
PLoS One
. 2024 Aug;
19(8):e0306178.
PMID: 39186751
Background: Despite advancements in percutaneous and surgical revascularization techniques, nearly 20% of patients who undergo myocardial revascularization need repeat revascularization. Recently, identified as a prognostication factor for adverse cardiovascular events,...
4.
Koyuncu A, Yildiz C, Oflar E, Mavi B, Ertugrul A, Ocal L, et al.
Echocardiography
. 2024 Jul;
41(7):e15882.
PMID: 38979721
Background: The prognosis of hypertrophic cardiomyopathy (HCM) varies from mild disease with a normal life expectancy to heart failure and sudden cardiac death (SCD). The identification of patients who are...
5.
Oflar E, Akdeniz E, Yildiz C, Koyuncu A, Mavi B, Karabulut D, et al.
Vascular
. 2024 May;
32(4):797-803.
PMID: 38705727
Objective: Predictive value of systemic immune-inflammation index (SII) has been shown in clinical outcomes and complexity of coronary artery disease, acute coronary syndrome, and heart failure. We sight to evaluate...
6.
Yildiz C, Koyuncu A, Ocal L, Gursoy M, Oflar E, Kahveci G
Cardiovasc J Afr
. 2023 Mar;
34(3):169-174.
PMID: 36947167
Objectives: We aimed to evaluate and compare papillary muscle free strain in hypertrophic cardiomyopathy (HCMP) and hypertensive (HT) patients. Methods: Global longitudinal strain (GLS), and longitudinal myocardial strain of the...
7.
Koyuncu A, Yildiz C, Ocal L, Kalkan S, Kilicgedik A, Gursoy M, et al.
PLoS One
. 2023 Feb;
18(2):e0282054.
PMID: 36827304
Background: Papillary muscle free strain has not been evaluated previously in hypertrophic cardiomyopathy (HCMP) patients. Our aim was to evaluate free papillary muscle free strain in HCMP patients and to...
8.
Oflar E, Sahin M, Demir B, Ertugrul A, Oztas D, Beyaz M, et al.
Arq Bras Cardiol
. 2022 Mar;
118(2):400-408.
PMID: 35262572
Background: It has been shown that interleukin-35 (IL-35) subunits are strongly expressed in atherosclerotic plaques in humans. Therefore, it is considered to play a role in atherosclerosis. Objectives: In this...
9.
Akturk I, Yildiz C, Karabulut D, Oflar E, Sahin A, Ertugrul A, et al.
Acta Cardiol
. 2021 Aug;
77(8):720-728.
PMID: 34427169
Background: In this study, we aimed to compare the management and clinical outcomes of patients with acute coronary syndrome (ACS) before and during pandemic. Methods: A total of 239 patients...
10.
Barman H, Atici A, Sahin I, Alici G, Tekin E, Baycan O, et al.
Coron Artery Dis
. 2020 Jun;
32(5):359-366.
PMID: 32568741
Objective: COVID-19 is a disease with high mortality, and risk factors for worse clinical outcome have not been well-defined yet. The aim of this study is to delineate the prognostic...